Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Scambia

Showing results (381-390 of 551) with videos related to

Pageof 56
Sort By:
International Journal of Cancer|February 1, 2000
Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumorsF O Ranelletti, N Maggiano, F G Serra, et al.
The International Journal of Artificial Organs|December 1, 1993
Five-year experience in PBSC collection: results of the Catholic University of RomeG Menichella, L Pierelli, M Vittori, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible targetG Scambia, F O Ranelletti, P B Panici, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|January 9, 2019
Synchronous primary cancers of endometrium and ovary vs endometrial cancer with ovarian metastasis: an observational studyF Moro, M Leombroni, T Pasciuto, et al.
British Journal of Cancer|October 29, 2002
Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implicationsG Ferrandina, L Lauriola, G F Zannoni, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2003
Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: a phase II studyG Di Vagno, G Cormio, S Pignata, et al.
British Journal of Haematology|August 1, 1990
Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoidsL M Larocca, M Piantelli, G Leone, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sitesG Scambia, F O Ranelletti, P Benedetti Panici, et al.
Menopause (New York, N.Y.)|April 4, 2000
Clinical effects of a standardized soy extract in postmenopausal women: a pilot studyG Scambia, D Mango, P G Signorile, et al.
International Journal of Cancer|January 2, 1994
Significance of epidermal growth factor receptor expression in primary human endometrial cancerG Scambia, P Benedetti Panici, G Ferrandina, et al.
Pageof 56

Showing results (381-390 of 551) with videos related to

Sort By:
Pageof 56
International Journal of Cancer|February 1, 2000
Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumorsF O Ranelletti, N Maggiano, F G Serra, et al.
The International Journal of Artificial Organs|December 1, 1993
Five-year experience in PBSC collection: results of the Catholic University of RomeG Menichella, L Pierelli, M Vittori, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible targetG Scambia, F O Ranelletti, P B Panici, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|January 9, 2019
Synchronous primary cancers of endometrium and ovary vs endometrial cancer with ovarian metastasis: an observational studyF Moro, M Leombroni, T Pasciuto, et al.
British Journal of Cancer|October 29, 2002
Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implicationsG Ferrandina, L Lauriola, G F Zannoni, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2003
Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: a phase II studyG Di Vagno, G Cormio, S Pignata, et al.
British Journal of Haematology|August 1, 1990
Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoidsL M Larocca, M Piantelli, G Leone, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sitesG Scambia, F O Ranelletti, P Benedetti Panici, et al.
Menopause (New York, N.Y.)|April 4, 2000
Clinical effects of a standardized soy extract in postmenopausal women: a pilot studyG Scambia, D Mango, P G Signorile, et al.
International Journal of Cancer|January 2, 1994
Significance of epidermal growth factor receptor expression in primary human endometrial cancerG Scambia, P Benedetti Panici, G Ferrandina, et al.
Pageof 56